Hikma Pharmaceuticals’s US subsidiary West-Ward Pharmaceuticals has launched Ethacrynic Acid Tablets USP in 25mg strength, the generic equivalent to Edecrin (ethacrynic acid) for the treatment of edema when an agent with greater diuretic potential than those commonly employed is required.
According to IMS Health, US sales of Ethacrynic Acid Tablets USP in 25mg strength were approximately $55 million for the 12 months ending March 2017, Hikma said in its press release on Wednesday.